Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fulvestrant by Kashiv BioSciences for Metastatic Breast Cancer: Likelihood of Approval
Fulvestrant is under clinical development by Kashiv BioSciences and currently in Phase I for Metastatic Breast Cancer. According to GlobalData,...
Fulvestrant by AstraZeneca for Ovarian Cancer: Likelihood of Approval
Fulvestrant is under clinical development by AstraZeneca and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...
Fulvestrant by AstraZeneca for Uterine Cancer: Likelihood of Approval
Fulvestrant is under clinical development by AstraZeneca and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II...
Fulvestrant by AstraZeneca for Leiomyosarcoma: Likelihood of Approval
Fulvestrant is under clinical development by AstraZeneca and currently in Phase II for Leiomyosarcoma. According to GlobalData, Phase II drugs...